Copyright Reports & Markets. All rights reserved.

Global GABA Receptor Agonist Drug Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Global GABA Receptor Agonist Drug Market Research Report 2018

      1 GABA Receptor Agonist Drug Market Overview

      • 1.1 Product Overview and Scope of GABA Receptor Agonist Drug
      • 1.2 GABA Receptor Agonist Drug Segment by Type (Product Category)
        • 1.2.1 Global GABA Receptor Agonist Drug Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
        • 1.2.2 Global GABA Receptor Agonist Drug Production Market Share by Type (Product Category) in 2017
        • 1.2.3 Bamaluzole
        • 1.2.3 Phenibut
        • 1.2.5 Baclofen
        • 1.2.6 Gaboxadol
        • 1.2.7 Klonopin (clonazepam)

      Tiagbine

      • 1.3 Global GABA Receptor Agonist Drug Segment by Application
        • 1.3.1 GABA Receptor Agonist Drug Consumption (Sales) Comparison by Application (2013-2025)
        • 1.3.2 Attention Deficit Hyperactivity Disorder (ADHD)
        • 1.3.3 Psychiatric Disorders and Depression
        • 1.3.4 Alzheimer
        • 1.3.5 Epilepsy and Seizure
        • 1.3.6 Anxiety and Sleep Disorders
        • 1.3.7 Obesity and Alcoholism
      • 1.4 Global GABA Receptor Agonist Drug Market by Region (2013-2025)
        • 1.4.1 Global GABA Receptor Agonist Drug Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
        • 1.4.2 North America Status and Prospect (2013-2025)
        • 1.4.3 Europe Status and Prospect (2013-2025)
        • 1.4.4 China Status and Prospect (2013-2025)
        • 1.4.5 Japan Status and Prospect (2013-2025)
        • 1.4.6 Southeast Asia Status and Prospect (2013-2025)
        • 1.4.7 India Status and Prospect (2013-2025)
      • 1.5 Global Market Size (Value) of GABA Receptor Agonist Drug (2013-2025)
        • 1.5.1 Global GABA Receptor Agonist Drug Revenue Status and Outlook (2013-2025)
        • 1.5.2 Global GABA Receptor Agonist Drug Capacity, Production Status and Outlook (2013-2025)

      2 Global GABA Receptor Agonist Drug Market Competition by Manufacturers

      • 2.1 Global GABA Receptor Agonist Drug Capacity, Production and Share by Manufacturers (2013-2018)
        • 2.1.1 Global GABA Receptor Agonist Drug Capacity and Share by Manufacturers (2013-2018)
        • 2.1.2 Global GABA Receptor Agonist Drug Production and Share by Manufacturers (2013-2018)
      • 2.2 Global GABA Receptor Agonist Drug Revenue and Share by Manufacturers (2013-2018)
      • 2.3 Global GABA Receptor Agonist Drug Average Price by Manufacturers (2013-2018)
      • 2.4 Manufacturers GABA Receptor Agonist Drug Manufacturing Base Distribution, Sales Area and Product Type
      • 2.5 GABA Receptor Agonist Drug Market Competitive Situation and Trends
        • 2.5.1 GABA Receptor Agonist Drug Market Concentration Rate
        • 2.5.2 GABA Receptor Agonist Drug Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global GABA Receptor Agonist Drug Capacity, Production, Revenue (Value) by Region (2013-2018)

      • 3.1 Global GABA Receptor Agonist Drug Capacity and Market Share by Region (2013-2018)
      • 3.2 Global GABA Receptor Agonist Drug Production and Market Share by Region (2013-2018)
      • 3.3 Global GABA Receptor Agonist Drug Revenue (Value) and Market Share by Region (2013-2018)
      • 3.4 Global GABA Receptor Agonist Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.5 North America GABA Receptor Agonist Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.6 Europe GABA Receptor Agonist Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.7 China GABA Receptor Agonist Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.8 Japan GABA Receptor Agonist Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.9 Southeast Asia GABA Receptor Agonist Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.10 India GABA Receptor Agonist Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

      4 Global GABA Receptor Agonist Drug Supply (Production), Consumption, Export, Import by Region (2013-2018)

      • 4.1 Global GABA Receptor Agonist Drug Consumption by Region (2013-2018)
      • 4.2 North America GABA Receptor Agonist Drug Production, Consumption, Export, Import (2013-2018)
      • 4.3 Europe GABA Receptor Agonist Drug Production, Consumption, Export, Import (2013-2018)
      • 4.4 China GABA Receptor Agonist Drug Production, Consumption, Export, Import (2013-2018)
      • 4.5 Japan GABA Receptor Agonist Drug Production, Consumption, Export, Import (2013-2018)
      • 4.6 Southeast Asia GABA Receptor Agonist Drug Production, Consumption, Export, Import (2013-2018)
      • 4.7 India GABA Receptor Agonist Drug Production, Consumption, Export, Import (2013-2018)

      5 Global GABA Receptor Agonist Drug Production, Revenue (Value), Price Trend by Type

      • 5.1 Global GABA Receptor Agonist Drug Production and Market Share by Type (2013-2018)
      • 5.2 Global GABA Receptor Agonist Drug Revenue and Market Share by Type (2013-2018)
      • 5.3 Global GABA Receptor Agonist Drug Price by Type (2013-2018)
      • 5.4 Global GABA Receptor Agonist Drug Production Growth by Type (2013-2018)

      6 Global GABA Receptor Agonist Drug Market Analysis by Application

      • 6.1 Global GABA Receptor Agonist Drug Consumption and Market Share by Application (2013-2018)
      • 6.2 Global GABA Receptor Agonist Drug Consumption Growth Rate by Application (2013-2018)
      • 6.3 Market Drivers and Opportunities
        • 6.3.1 Potential Applications
        • 6.3.2 Emerging Markets/Countries

      7 Global GABA Receptor Agonist Drug Manufacturers Profiles/Analysis

      • 7.1 Advicenne
        • 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.1.2 GABA Receptor Agonist Drug Product Category, Application and Specification
          • 7.1.2.1 Product A
          • 7.1.2.2 Product B
        • 7.1.3 Advicenne GABA Receptor Agonist Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.1.4 Main Business/Business Overview
      • 7.2 AstraZeneca
        • 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.2.2 GABA Receptor Agonist Drug Product Category, Application and Specification
          • 7.2.2.1 Product A
          • 7.2.2.2 Product B
        • 7.2.3 AstraZeneca GABA Receptor Agonist Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.2.4 Main Business/Business Overview
      • 7.3 Athena Drug Delivery Solutions
        • 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.3.2 GABA Receptor Agonist Drug Product Category, Application and Specification
          • 7.3.2.1 Product A
          • 7.3.2.2 Product B
        • 7.3.3 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.3.4 Main Business/Business Overview
      • 7.4 Biocodex
        • 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.4.2 GABA Receptor Agonist Drug Product Category, Application and Specification
          • 7.4.2.1 Product A
          • 7.4.2.2 Product B
        • 7.4.3 Biocodex GABA Receptor Agonist Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.4.4 Main Business/Business Overview
      • 7.5 Elan Corporation
        • 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.5.2 GABA Receptor Agonist Drug Product Category, Application and Specification
          • 7.5.2.1 Product A
          • 7.5.2.2 Product B
        • 7.5.3 Elan Corporation GABA Receptor Agonist Drug Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
        • 7.5.4 Main Business/Business Overview
      • 7.6 Eli Lilly and Company
        • 7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.6.2 GABA Receptor Agonist Drug Product Category, Application and Specification
          • 7.6.2.1 Product A
          • 7.6.2.2 Product B
        • 7.6.3 Eli Lilly and Company GABA Receptor Agonist Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.6.4 Main Business/Business Overview
      • 7.7 H.LundBeck, Merck and Co
        • 7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.7.2 GABA Receptor Agonist Drug Product Category, Application and Specification
          • 7.7.2.1 Product A
          • 7.7.2.2 Product B
        • 7.7.3 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.7.4 Main Business/Business Overview
      • 7.8 GlaxoSmithKline
        • 7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.8.2 GABA Receptor Agonist Drug Product Category, Application and Specification
          • 7.8.2.1 Product A
          • 7.8.2.2 Product B
        • 7.8.3 GlaxoSmithKline GABA Receptor Agonist Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.8.4 Main Business/Business Overview
      • 7.9 NovaDel Pharma
        • 7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.9.2 GABA Receptor Agonist Drug Product Category, Application and Specification
          • 7.9.2.1 Product A
          • 7.9.2.2 Product B
        • 7.9.3 NovaDel Pharma GABA Receptor Agonist Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.9.4 Main Business/Business Overview
      • 7.8 Novartis
        • 7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.10.2 GABA Receptor Agonist Drug Product Category, Application and Specification
          • 7.10.2.1 Product A
          • 7.10.2.2 Product B
        • 7.10.3 Novartis GABA Receptor Agonist Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.10.4 Main Business/Business Overview
      • 7.11 OVATION Pharmaceuticals
      • 7.12 Osmotica Pharmaceutical
      • 7.13 Pfizer
      • 7.14 sanofi-aventis
      • 7.15 VIVUS
      • 7.16 XenoPort

      8 GABA Receptor Agonist Drug Manufacturing Cost Analysis

      • 8.1 GABA Receptor Agonist Drug Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
        • 8.1.4 Market Concentration Rate of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
        • 8.2.1 Raw Materials
        • 8.2.2 Labor Cost
        • 8.2.3 Manufacturing Expenses
      • 8.3 Manufacturing Process Analysis of GABA Receptor Agonist Drug

      9 Industrial Chain, Sourcing Strategy and Downstream Buyers

      • 9.1 GABA Receptor Agonist Drug Industrial Chain Analysis
      • 9.2 Upstream Raw Materials Sourcing
      • 9.3 Raw Materials Sources of GABA Receptor Agonist Drug Major Manufacturers in 2017
      • 9.4 Downstream Buyers

      10 Marketing Strategy Analysis, Distributors/Traders

      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
        • 10.1.3 Marketing Channel Development Trend
      • 10.2 Market Positioning
        • 10.2.1 Pricing Strategy
        • 10.2.2 Brand Strategy
        • 10.2.3 Target Client
      • 10.3 Distributors/Traders List

      11 Market Effect Factors Analysis

      • 11.1 Technology Progress/Risk
        • 11.1.1 Substitutes Threat
        • 11.1.2 Technology Progress in Related Industry
      • 11.2 Consumer Needs/Customer Preference Change
      • 11.3 Economic/Political Environmental Change

      12 Global GABA Receptor Agonist Drug Market Forecast (2018-2025)

      • 12.1 Global GABA Receptor Agonist Drug Capacity, Production, Revenue Forecast (2018-2025)
        • 12.1.1 Global GABA Receptor Agonist Drug Capacity, Production and Growth Rate Forecast (2018-2025)
        • 12.1.2 Global GABA Receptor Agonist Drug Revenue and Growth Rate Forecast (2018-2025)
        • 12.1.3 Global GABA Receptor Agonist Drug Price and Trend Forecast (2018-2025)
      • 12.2 Global GABA Receptor Agonist Drug Production, Consumption , Import and Export Forecast by Region (2018-2025)
        • 12.2.1 North America GABA Receptor Agonist Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.2 Europe GABA Receptor Agonist Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.3 China GABA Receptor Agonist Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.4 Japan GABA Receptor Agonist Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.5 Southeast Asia GABA Receptor Agonist Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.6 India GABA Receptor Agonist Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
      • 12.3 Global GABA Receptor Agonist Drug Production, Revenue and Price Forecast by Type (2018-2025)
      • 12.4 Global GABA Receptor Agonist Drug Consumption Forecast by Application (2018-2025)

      13 Research Findings and Conclusion

        14 Appendix

        • 14.1 Methodology/Research Approach
          • 14.1.1 Research Programs/Design
          • 14.1.2 Market Size Estimation
          • 14.1.3 Market Breakdown and Data Triangulation
        • 14.2 Data Source
          • 14.2.1 Secondary Sources
          • 14.2.2 Primary Sources

        This report studies the global GABA Receptor Agonist Drug market status and forecast, categorizes the global GABA Receptor Agonist Drug market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

        The major manufacturers covered in this report
        Advicenne
        AstraZeneca
        Athena Drug Delivery Solutions
        Biocodex
        Elan Corporation
        Eli Lilly and Company
        H.LundBeck, Merck and Co
        GlaxoSmithKline
        NovaDel Pharma
        Novartis
        OVATION Pharmaceuticals
        Osmotica Pharmaceutical
        Pfizer
        sanofi-aventis
        VIVUS
        XenoPort

        Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        We can also provide the customized separate regional or country-level reports, for the following regions:
        North America
        United States
        Canada
        Mexico
        Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Rest of Asia-Pacific
        Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
        Central & South America
        Brazil
        Argentina
        Rest of South America
        Middle East & Africa
        Saudi Arabia
        Turkey
        Rest of Middle East & Africa

        On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
        Bamaluzole
        Phenibut
        Baclofen
        Gaboxadol
        Klonopin (clonazepam)
        Tiagbine
        On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
        Attention Deficit Hyperactivity Disorder (ADHD)
        Psychiatric Disorders and Depression
        Alzheimer
        Epilepsy and Seizure
        Anxiety and Sleep Disorders
        Obesity and Alcoholism

        The study objectives of this report are:
        To analyze and study the global GABA Receptor Agonist Drug capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
        Focuses on the key GABA Receptor Agonist Drug manufacturers, to study the capacity, production, value, market share and development plans in future.
        Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
        To define, describe and forecast the market by type, application and region.
        To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
        To identify significant trends and factors driving or inhibiting the market growth.
        To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
        To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
        To strategically profile the key players and comprehensively analyze their growth strategies.

        In this study, the years considered to estimate the market size of GABA Receptor Agonist Drug are as follows:
        History Year: 2013-2017
        Base Year: 2017
        Estimated Year: 2018
        Forecast Year 2018 to 2025

        For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

        Key Stakeholders
        GABA Receptor Agonist Drug Manufacturers
        GABA Receptor Agonist Drug Distributors/Traders/Wholesalers
        GABA Receptor Agonist Drug Subcomponent Manufacturers
        Industry Association
        Downstream Vendors

        Available Customizations
        With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
        Regional and country-level analysis of the GABA Receptor Agonist Drug market, by end-use.
        Detailed analysis and profiles of additional market players.

        Buy now